Loading
Life sciences · Journal article
Immunology · October 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT The nervous and immune systems, once viewed as distinct biological networks, are now understood to be closely linked in regulating cancer development, progression, and responses to therapy. Neural structures infiltrate the tumour microenvironment and communicate with immune cells, influencing key processes such as tumour growth, invasion, and metastatic spread. Through neurotransmitters, neuropeptides, and continuous signalling between peripheral tissues and the brain, nerves affect immune cell recruitment, activity, and overall immune balance. Factors including psychological stress, circadian rhythm disturbances, and gut–brain communication further shape antitumour immune responses, highlighting the complexity of these interactions. Research suggests that neuronal signalling not only contributes to cancer‐associated symptoms, such as pain, but also affects the efficacy of chemotherapy, radiotherapy, and immunotherapy. Neural biomarkers may provide prognostic value, while interventions targeting neural pathways could strengthen anticancer immunity. Nevertheless, major challenges remain, including cellular heterogeneity, dynamic spatial and temporal interactions, and the limitations of existing experimental models. Continued progress in molecular techniques, bioinformatics, and cross‐disciplinary research will be crucial for clarifying these mechanisms. Investigating the neuro–immune–cancer interface offers significant potential for developing innovative treatment approaches that combine neuroscience, immunology, and oncology to enhance patient survival and quality of life.